Why the study?
Acquired cardiovascular conditions are a leading cause of maternal morbidity and mortality, with increasing prevalence expected as the average childbearing age rises.
This document provides practical guidance on the management of acquired cardiovascular conditions in women from pre-conception through pregnancy and postpartum.
Answers are grounded in this paper and cite their sources.
Standardizes care for acquired CVD across peripartum period; reinforces multidisciplinary approaches to optimize maternal-fetal outcomes.
Acquired cardiovascular conditions are a leading cause of maternal morbidity and mortality. A growing number of pregnant women have acquired and heritable cardiovascular conditions and cardiovascular risk factors. As the average age of childbearing women increases, the prevalence of acute coronary syndromes, cardiomyopathy, and other cardiovascular complications in pregnancy are also expected to increase. This document, the third of a 5-part series, aims to provide practical guidance on the management of such conditions encompassing pre-conception through acute management and considerations for delivery.
No takes yet. Share an insight, caveat, or question.
Park et al. (2021) conducted a review in Acquired cardiovascular conditions in pregnancy. Management guidance was evaluated. This guidance document outlines practical management strategies for women with acquired cardiovascular conditions from pre-conception through pregnancy and the postpartum period.
Synapse has enriched 10 related papers. Consider them for comparative context: